Get the Stockscreener App
117.69
0.09%
-0.1935
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $117.69, with a volume of 95,293.
It is down -0.09% in the last 24 hours and up +6.00% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$117.88
Open:
$118.25
24h Volume:
95,293
Relative Volume:
0.07
Market Cap:
$13.12B
Revenue:
$2.90B
Net Income/Loss:
$239.11M
P/E Ratio:
55.78
EPS:
2.1097
Net Cash Flow:
$492.62M
1W Performance:
+3.09%
1M Performance:
+6.00%
6M Performance:
+22.64%
1Y Performance:
+29.52%
1-Day Range:
$115.67
$118.34
1-Week Range:
$112.68
$118.34
52-Week Range:
$81.22
$118.34
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
117.55 | 13.15B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
600.58 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.34 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
311.57 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
569.52 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.82 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Understanding the Setup: (RVTY) and Scalable Risk - Stock Traders Daily
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q) - marketscreener.com
Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit - Stock Titan
Revvity (RVTY) Q2 2026 Earnings Call Transcript - AOL.com
Revvity to Present at Upcoming Investor Conferences - Business Wire
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Revvity Launches Superflex Prenatal Screening System - marketscreener.com
Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation With A 5.59% Upside - directorstalkinterviews.com
Bank of America Corp DE Increases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity Q2 Earnings Call Highlights - TradingView
Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative - webull.com
Revvity (NYSE:RVTY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (0KHE) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
REVVITY, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $100 - webull.com
Revvity (NYSE:RVTY) Rating Increased to Hold at Zacks Research - MarketBeat
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY? - Yahoo Finance
Why Revvity (RVTY) Stock Is Up Today - The Globe and Mail
Stifel raises Revvity stock price target to $110 on earnings beat - Investing.com
REVVITY, INC. : JP MORGAN RAISES TARGET PRICE TO $110 FROM $90 - Moomoo
Revvity posts solid Q2 2026 earnings growth - The Globe and Mail
Amundi Sells 32,858 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Stock Premium Faces Pressure From Thin Margins - Sahm
Revvity, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Revvity Inc (RVTY) Shares Fall 3.3% -- What GF Score of 75 Tells Investors - GuruFocus
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
No-Moat Revvity Sees Solid First-Half Performance With Momentum Likely to Continue - Morningstar
Revvity, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:RVTY) 2026-08-04 - Seeking Alpha
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up - Yahoo Finance
Earnings call transcript: Revvity beats Q2 2026 estimates, but shares fall premarket - Investing.com
Revvity Inc (RVTY) (Q2 2026) Earnings Call Highlights: Strong Di - GuruFocus
Revvity, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Revvity (NYSE:RVTY) Issues FY 2026 Earnings Guidance - MarketBeat
Revvity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 05, 2026 - marketscreener.com
Revvity raises annual profit, revenue forecasts on strong diagnostics demand - Yahoo! Finance Canada
Revvity Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Revvity Inc (RVTY) Undervalued? Q2 Earnings Report Shows GAAP - GuruFocus
Transcript: Revvity Q2 2026 Earnings Conference Call - Benzinga
Revvity Tops Second-Quarter Estimates and Lifts Full-Year Outlook - Yahoo Finance
Q2 2026 Revvity Inc Earnings Call Transcript - GuruFocus
Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Revvity beats estimates, raises guidance as stock jumps - Investing.com
Earnings Flash (RVTY) Revvity, Inc. Reports Q2 Revenue $729.7M, vs. FactSet Est of $703.0M - marketscreener.com
Earnings Flash (RVTY) Revvity, Inc. Posts Q2 Adjusted EPS $1.41 per Share, vs. FactSet Est of $1.21 - marketscreener.com
Revvity Q2 revenue rises to $730 million as company raises 2026 guidance - Quiver Quantitative
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
0.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):